anti-claudin 18.2 antibody-drug conjugate eo-3021 vs larotrectinib
| anti-claudin 18.2 antibody-drug conjugate eo-3021 | larotrectinib | |
|---|---|---|
| Developers | 0 | 2 |
| Clinical trials | 0 | 0 |
| FDA decisions | 0 | 0 |
| Generic name | Anti-Claudin 18.2 Antibody-drug Conjugate EO-3021 | LAROTRECTINIB SULFATE |